NTRK Testing: Practical Considerations for IHC Interpretation

Logo
Presented by

Dr. Lawrence Weiss and Dr. Fernando López-Ríos

About this talk

As pan-TRK IHC evaluation becomes a more integrated part of NTRK testing in clinical practice, take the opportunity to learn from Dr. Lawrence Weiss (US) and Dr. Fernando López-Ríos (Spain), who are internationally-recognized leaders on the topic. They will present selected cases to cover diverse histologies and offer a pragmatic overview of pan-TRK IHC interpretation. Practical tips and tricks for the optimal interpretation of findings will be discussed along with a series of relevant questions from practicing pathologists.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (65)
Subscribers (9077)
This series is brought to you by Roche. We are committed to providing you with educational content, from key opinion leaders, related to personalized
diagnostics. We aim to ensure on ongoing conversation is taking place in this evolving area of healthcare. Roche is a global pioneer in pharmaceuticals and
diagnostics focused on advancing science to improve people’s lives. Roche is the world’s largest biotech company, with truly differentiated medicines in
oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics…